Remove 2025 Remove Medical science Remove Networking
article thumbnail

Amgen and Pfizer appoint new Science executives

European Pharmaceutical Review

Dr Boshoff will begin this new role on 1 January 2025 and will oversee all R&D functions across every therapeutic area in the company. He earned his medical degree from University of Pretoria in South Africa, a doctorate PhD from the Institute of Cancer Research in London. Academy of Medical Sciences. “I Pfizer Inc.

article thumbnail

Life sciences response to 2024 Autumn Budget

European Pharmaceutical Review

For instance, the £520 million life sciences innovative manufacturing fund “is very welcome, and will be crucial in helping to capture high-productivity investment, and create valuable jobs at a time when they are most needed,” remarked Richard Torbett, Chief Executive, ABPI.